Good Morning! Latin America: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Good Morning! Latin America.

Press releases published on October 22, 2026

Oct. 22, 2026

SCYNEXIS Completes Phase 1 Study of Intravenous SCY-247, a Novel, Triterpenoid Antifungal in Development for Treatment and Prevention of Invasive Fungal Diseases

Indeterminate GlobeNewswire

Oct. 22, 2026

Rectify to Present Translational Data Supporting RTY-406 as a Transformative Therapy for PSC and Other Hepatobiliary Diseases

Indeterminate GlobeNewswire

Oct. 22, 2026

Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

GoldHaven Intersects Multiple Polymetallic Sulphide Zones at Magno, Including Up to 13 Metres in D Zone Drilling

Indeterminate GlobeNewswire

Oct. 22, 2026

Precore Gold Strengthens Board and Management with Leading Mining and Capital Markets Executives

Indeterminate GlobeNewswire

Oct. 22, 2026

NevGold Extends Oxide Mineralization By Over 100 Meters: 7.27 g/t AuEq Over 3.0 Meters (6.18 g/t Au, 0.28% Sb) Within 1.55 g/t AuEq Over 32.0 Meters (0.92 g/t Au, 0.16% Sb); And 8.04 g/t AuEq Over 3.0 Meters (0.36 g/t Au, 1.98% Sb) Within 0.42% Sb Over…

Indeterminate GlobeNewswire

Oct. 22, 2026

BridgeBio to Report Third Quarter 2026 Financial Results and Commercial Updates on October 29, 2026 at 4:30 pm ET

Indeterminate GlobeNewswire

Oct. 22, 2026

Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Indeterminate GlobeNewswire

Oct. 22, 2026

G3 Goldfields Receives Final CSE Listing Approval; Trading to Commence October 26, 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

BPGbio Appoints Jason Krause as Senior Vice President and General Counsel

Indeterminate GlobeNewswire

Oct. 22, 2026

Tecnoglass Sets Date for Third Quarter 2026 Results

Indeterminate GlobeNewswire

Oct. 22, 2026

Sundance Biosciences Announces First Patient Dosed in U.S. Phase 2 Clinical Trial of SUN-627 for Progressive Forms of Multiple Sclerosis (MS)

Indeterminate GlobeNewswire

Oct. 22, 2026

MC Brazil Downstream Trading S.à r.l. Announces Early Tender Results and Receipt of All Required Consents in Connection with Its Tender Offer for Any and All of Its Outstanding 7.250% Senior Secured Notes Due 2031 and Related Consent Solicitation

Indeterminate GlobeNewswire

Oct. 22, 2026

Medicenna to Present Preclinical Data on Its CD122 Superantagonist MDNA209 at The Promises of Treg and Interleukin-2 Therapies Conference

Indeterminate GlobeNewswire

Oct. 22, 2026

Rakovina Therapeutics and Variational AI Advance Brain-Penetrant ATR Program Toward Development Candidate Selection

Indeterminate GlobeNewswire

Oct. 22, 2026

Fortuna to release third quarter 2026 financial results on November 4, 2026; Conference call at 12 p.m. Eastern time on November 5, 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

Nxera Pharma Submits Marketing Authorization Application for Vamorolone in South Korea for the Treatment of Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

Oct. 22, 2026

Greenlight Innovation Syndicate 3456 Appoints Ian Maguire as Active Underwriter

Indeterminate GlobeNewswire

Oct. 22, 2026

Oculis Reports New Phase 2 ACUITY Biomarker Data Further Supporting Privosegtor’s Neuroprotective Potential in Optic Neuritis

Indeterminate GlobeNewswire

Oct. 22, 2026

Pharming Group announces third quarter 2026 revenues above market expectations

Indeterminate GlobeNewswire